Zacks.com on MSN2d
Boston Scientific Gains 42.2% in a Year: What's Driving the Stock?
BSX's shares rise on the back of its innovative product portfolio and impressive value-added acquisition. However, the unfavorable macroeconomic scenario is concerning.
Endoscopic Ultrasonography (EUS) Market to Hit USD 1.93 Billion by 2029 with 7.1% CAGR
The global endoscopic ultrasonography market, valued at US$1.28 billion in 2023, is forecasted to grow at a robust CAGR of ...
Nasdaq6d
Boston Scientific (BSX) Down 4% Since Last Earnings Report: Can It Rebound?
Boston Scientific posted fourth-quarter 2024 adjusted ... revenues from the sale of Medical Devices. Within this, the Endoscopy unit generated revenues of $690 million, up 7% organically.
Boston Scientific Corporation (BSX) TD Cowen 45th Annual Healthcare Conference (Transcript)
Boston Scientific Corporation ( NYSE: BSX) TD Cowen 45th Annual Healthcare Conference March 4, 2025 9:10 AM ET Dan Brennan - Chief Financial Officer Ken Stein - Chief Medical Officer Art Butcher - ...
Insider Monkey28d
Boston Scientific Corporation (BSX): Among the Best Momentum Stocks to Buy According to Hedge Funds
endoscopy, urology, and neuromodulation. In the past 12 months, the stock has surged by nearly 61%, which makes it one of the best momentum stocks. Boston Scientific Corporation (NYSE:BSX ...
Medscape3d
A Common Pancreatic Condition That Few Have Heard Of
Fatty pancreas disease, characterized by intra-pancreatic fat deposition, is more prevalent than diabetes, pancreatitis, and ...